| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 10/06/2005 | WO2004072031A8 Phenylacetamides and their use as glucokinase modulators |
| 10/06/2005 | US20050222438 Reacting aqueous ascorbic acid or isoascorbic acid solution with calcium nitrite in reaction vessel |
| 10/06/2005 | US20050222436 Reacting vanadium pentoxide with phosphoric acid in the presence of alcohol; isolating the precipitate formed, heat treatment, shaping the heat-treated product obtained into particles having an averaged diameter of at least 2 mm |
| 10/06/2005 | US20050222435 Reacting vanadium pentoxide in the presence of alcohol with phosphoric acid, heating, stirring and subsequently filtering the resultant suspension |
| 10/06/2005 | US20050222423 Carboxylic acid derivative |
| 10/06/2005 | US20050222414 N-(4-methylphenyl)-4-[4-[[(phenylmethoxy)amino]carbonyl]phenyl]-1-piperazinecarboxamide; anticarcinogenic, antiproliferative agent; ovarian carcinoma, psoriasis; gene transcription control |
| 10/06/2005 | US20050222412 Antibiotic; bactericides |
| 10/06/2005 | US20050222216 Carboxyoic acid compounds and drugs containing the compounds as the active ingredient |
| 10/06/2005 | US20050222200 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist |
| 10/06/2005 | US20050222146 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 10/06/2005 | US20050222129 Non-imidazole heterocyclic compounds |
| 10/06/2005 | US20050222088 Synthesis of chiral furan amino acids as novel peptide building blocks |
| 10/06/2005 | US20050221989 O-cyclopropyl-carboxanilides and their use as fungicides |
| 10/06/2005 | US20050217562 Process for the isolation of high purity crystalline citalopram base |
| 10/06/2005 | DE102004014620A1 2,4,6-phenylsubstituierte cyclische Ketoenole 2,4,6-substituted cyclic ketoenols |
| 10/06/2005 | CA2561076A1 2,4,6-phenylsubstituted cyclic ketoenoles |
| 10/06/2005 | CA2560584A1 Novel compounds for modulating cell proliferation |
| 10/06/2005 | CA2560526A1 Novel pharmaceutical compositions comprising agonists of the thyroid receptor |
| 10/06/2005 | CA2559733A1 Inhibitors of histone deacetylase |
| 10/06/2005 | CA2559035A1 Substituted heteroaryl- and phenylsulfamoyl compounds |
| 10/06/2005 | CA2557794A1 Opioid receptor antagonists |
| 10/05/2005 | EP1581510A2 1-aryl-2-hydroxyethyl amides as potassium channel openers |
| 10/05/2005 | EP1581496A2 2-substituted-3-propenamide derivatives and methods of using the same |
| 10/05/2005 | EP1581483A1 A PROCESS FOR THE PREPARATION OF RACEMIC CITALOPRAM DIOL AND/OR i S- /i OR i R- /i CITALOPRAM DIOLS AND THE USE OF SUCH DIOLS FOR THE PREPARATION OF RACEMIC CITALOPRAM, i R- /i CITALOPRAM AND/OR i S- /i CITALOPRAM |
| 10/05/2005 | EP1581479A1 Process for the synthesis of 3,3a,6,6a-tetrahydro-2h-cyclopentan[b]furan-2-one |
| 10/05/2005 | EP1581478A1 Dhodh-inhibitors and method for their identification |
| 10/05/2005 | EP1581477A1 Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 10/05/2005 | EP1581472A2 Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto |
| 10/05/2005 | EP1581470A1 2,6-dihalo-4-(3,3-dichloro-allyloxy)-benzylalcohole derivatives having insecticidal and acaricidal properties |
| 10/05/2005 | EP1581207A2 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
| 10/05/2005 | EP1419147B1 Process for preparing ascorbic acids using alkaline earth silicate catalysts |
| 10/05/2005 | CN1678602A 2-oxabicyclo 3.3.0 octane compounds, process for producing the same, optical resolver, method of separating diastereomer mixture, and method of optically resolving alcohol |
| 10/05/2005 | CN1678601A Process for preparing functionalized ªå-butyrolactiones from mucohalic acid |
| 10/05/2005 | CN1678573A Diarylurea derivatives and their use as chloride channel blockers |
| 10/05/2005 | CN1678571A Malononitrile compound and use thereof as pesticides |
| 10/05/2005 | CN1678561A Spirobifluorene derivatives, their preparation and uses thereof |
| 10/05/2005 | CN1678302A Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma |
| 10/05/2005 | CN1678202A Method for producing an avocado unsaponifiable rich in furan lipids |
| 10/05/2005 | CN1676525A Hydrophilic polymer-thunder good vine extract binding substance and its medicinal composition |
| 10/05/2005 | CN1221541C Process for preparation of citalopram |
| 10/05/2005 | CN1221540C Chiral sugarapple lactone compound modified by ether bond, its synthesis method and application |
| 10/05/2005 | CN1221526C Novel phenyl-propargyl ether derivatives |
| 10/05/2005 | CN1221514C Intermediate for preparing alkyl-dihalogeno phenyl substituted keto-enol |
| 10/05/2005 | CN1221509C Production process of butane tetra formic acid derivatives by means of coupled electrosynthesis |
| 10/05/2005 | CN1221505C Process for the production of alkanediol derivatives |
| 10/04/2005 | US6951877 Materials and methods for treating hypercholesterolemia |
| 09/29/2005 | WO2005090337A1 Opioid receptor antagonists |
| 09/29/2005 | WO2005090296A2 N-substituted benzene sulfonamides |
| 09/29/2005 | WO2005090290A1 Process for producing citalopram, intermediate therefor, and process for producing the same |
| 09/29/2005 | WO2005090284A1 Non-glycosylated/non-glycosidic/non-peptidic small molecule psgl-1 mimetics for the treatment of inflammatory disorders |
| 09/29/2005 | WO2005089745A1 Salvinorin derivatives and uses thereof |
| 09/29/2005 | US20050215800 Method for producing gamma-butyrolactone |
| 09/29/2005 | US20050215794 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency; forming a carbon-carbon bond between a reactant comprising a nucleophilic carbon atom, e.g., enolate or malonate anion, and activated carbon of an aryl, heteroaryl, or vinyl halide or sulfonate |
| 09/29/2005 | US20050215772 Furanone derivatives and methods of making same |
| 09/29/2005 | US20050215626 Substituted benzofuran oximes; inhibiting PAI-1 activity; Plasminogen Activator Inhibitor (PAI); treating thrombosis, pulmonary fibrosis, stroke, myocardial ischemia, cardiovascular disease, chronic obstructive pulmonary disease, diabetes, Alzheimer's disease, renal fibrosis, or cancer |
| 09/29/2005 | US20050215496 Preparation and diabetic use of Gibberellins |
| 09/29/2005 | US20050215493 Calcium-containing tissue strengthening agents and use thereof |
| 09/29/2005 | CA2559207A1 Salvinorin derivatives and uses thereof |
| 09/29/2005 | CA2559047A1 N-substituted benzene sulfonamides |
| 09/29/2005 | CA2558652A1 Opioid receptor antagonists |
| 09/28/2005 | EP1578741A1 Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 09/28/2005 | EP1578740A1 1,2,4-triaminobenzene derivatives useful for treating disorders of the central nervous system |
| 09/28/2005 | EP1578738A1 Escitalopram hydrobromide and a method for the preparation thereof |
| 09/28/2005 | EP1578715A2 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 09/28/2005 | EP1187800A4 Improved process for the preparation of 3,4-dihydroxybutanoic acid and salts and lactones derived therefrom |
| 09/28/2005 | CN1675191A Ultraviolet transmitting fluoropolymer and pellicle comprising said polymer |
| 09/28/2005 | CN1675190A Method for producing tetrahydrofuran |
| 09/28/2005 | CN1675185A Therapeutic molecules and methods-1 |
| 09/28/2005 | CN1675154A Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (MIF) |
| 09/28/2005 | CN1675144A Method for the separation of intermediates which may be used for the preparation of escitalopram |
| 09/28/2005 | CN1220682C Heterocycle derivatives inhibiting factor Xa |
| 09/27/2005 | US6949654 Treating diseases arising from reactive oxygen species and/or excess Zn ions, in particular stroke, Parkinson's disease and Alzheimer's disease. |
| 09/27/2005 | US6949615 Monomer having electron-withdrawing group and process for preparing the same |
| 09/27/2005 | US6949583 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method of preparing same and compositions containing same |
| 09/27/2005 | US6949574 (Oxime)carbamoyl fatty acid amide hydrolase inhibitors |
| 09/27/2005 | US6949572 Antilipemic or antilipolytic agents for treatment of obesity and lipid disorders, S)-N-{2-[benzyl(methyl)amino]-2-oxo-1-phenylethyl}-1-methyl-5-[4'-(trifluoromethyl)[1,1'-biphenyl]-2-carboxamido]-1H-indole-2-carboxamide |
| 09/27/2005 | US6949567 Asymmetric amidine-substituted diphenylureas; diseases treated by the inhibition of intracellular protein degradation pathways, e.g. proteases, proteasome; anticarcinogenic agents; immunological modulators |
| 09/27/2005 | US6949534 An amide compound containing a very late antigen of activation-4 (VLA-4) specifity determinanat which doesn't impart significant IIb/IIIa activity; antiinflammatory agent and useful for treating autoimmune disorders |
| 09/22/2005 | WO2005087757A1 Method for the production of tetrahydrofuran using a heteropoly acid as catalyst with exclusion of oxygen |
| 09/22/2005 | WO2005087756A1 Trisubstituted furans suitable for the preparation of fragrance compositions |
| 09/22/2005 | WO2005087754A1 Substituted morpholine and thiomorpholine derivatives |
| 09/22/2005 | WO2005087710A1 Aminophenylpropanoic acid derivative |
| 09/22/2005 | WO2005087700A2 Bisphenyl compounds useful as vitamin d3 receptor agonists |
| 09/22/2005 | WO2005087692A2 Process for recovering organic compounds from aqueous streams containing same |
| 09/22/2005 | WO2005087236A1 Novel m3 muscarinic acetylcholine receptor antagonists |
| 09/22/2005 | WO2005087222A1 C7 lactyloxy-substituted taxanes |
| 09/22/2005 | WO2005087215A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors |
| 09/22/2005 | US20050209467 Process for the preparation of 1 - (3-dimethylaminopropyl) -1 - (4-fluorophenyl) -1,3-dihydroisobenzofuran-5-carbonitrile |
| 09/22/2005 | US20050209337 Process for the preparation of prostaglandin derivatives |
| 09/22/2005 | US20050209316 Lactone formulations and method of use |
| 09/22/2005 | US20050209311 C7 lactyloxy-substituted taxanes |
| 09/22/2005 | US20050209214 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 09/22/2005 | US20050209199 Anti-sickling agents |
| 09/22/2005 | US20050209197 Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds |
| 09/22/2005 | US20050208402 Electrophotographic photosensitive member, process cartridge and electrophotographic apparatus |
| 09/22/2005 | US20050208197 Agonists/antagonists of muscarine M3 receptors, obtained from beer through isolation and purification; distillation; chromatography; side effect reduction |
| 09/22/2005 | DE102004012114A1 Verfahren zur Herstellung von Tetrahydrofuran A process for the production of tetrahydrofuran |
| 09/22/2005 | DE102004009150A1 Use of ascorbic acid and/or its derivatives for cleansing and/or reducing size of skin pores includes use in cosmetics and dermatics, e.g. emulsion or mousse for skin or face, day or night cream or lotion |
| 09/22/2005 | CA2560111A1 Aminophenylpropanoic acid derivative |
| 09/22/2005 | CA2558249A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors |